Federal Register: April 16, 2004 (Volume 69, Number 74)
DOCID: FR Doc 04-8612
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Docket ID: [Docket No. 2003N-0267]
DOCUMENT ACTION: Notice.
Agency Information Collection Activities; Announcement of OMB Approval; Postmarketing Studies for Human Drugs and Licensed Biological Products; Status Report
The Food and Drug Administration (FDA) is announcing that a collection of information entitled ``Postmarketing Studies for Human Drugs and Licensed Biological Products; Status Report'' has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Agency information collection activities; proposals, submissions, and approvals,
In the Federal Register of January 16, 2004
(69 FR 2601), the agency announced that the proposed information
collection had been submitted to OMB for review and clearance under 44
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not
required to respond to, a collection of information unless it displays a currently valid OMB control
number. OMB has now approved the information collection and has assigned OMB control number 09100433. The approval expires on March 31, 2007. A copy of the supporting statement for this information collection is available on the Internet at http://www.fda.gov/ohrms/dockets .
Dated: April 9, 2004.
Assistant Commissioner for Policy.
[FR Doc. 048612 Filed 41504; 8:45 am]
BILLING CODE 416001S
FOR FURTHER INFORMATION CONTACT
JonnaLynn P. Capezzuto, Office of Information Resources Management (HFA250), Food and Drug
Administration, 5600 Fishers Lane, Rockville, MD 20857, 3018274659.